A new study suggests inhibiting ActivinA might improve the efficacy of chemotherapy in patients with B-cell acute lymphoblastic leukemia (B-ALL). ActivinA appears to support the survival of leukemia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback